Addex’s ADX48621 Effective in Preclinical Parkinson’s Disease Studies

Addex Executive Management Change

Addex R&D Day Highlights

Addex Shareholders Approve All Board Proposals at 2010 AGM

Addex to Host R&D Day on May 11

Addex Pharmaceuticals 2009 Financial Results

Addex to Present at The New York Academy of Sciences

Addex to Host 2009 Financial Results Call on Feb. 23

Addex: ADX71943 Demonstrates Analgesic Effects in Pain Models

Development of ADX10059 Ended for Long-term Use